z-logo
open-access-imgOpen Access
Characteristics and Treatment Outcomes among HIV‐Infected Individuals in the Australian Trial in Acute Hepatitis C
Author(s) -
Gail Matthews,
Margaret Hellard,
Paul Haber,
Barbara Yeung,
P. Marks,
Damon L Baker,
Geoffrey W. McCaughan,
Joe Sasadeusz,
Peter A. White,
William D. Rawlinson,
Andrew R. Lloyd,
John Kaldor,
G.J. Dore
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/596770
Subject(s) - medicine , natural history , human immunodeficiency virus (hiv) , hepatitis c , cohort , prospective cohort study , hepatitis c virus , cohort study , immunology , virology , family medicine , virus
The Australian Trial in Acute Hepatitis C (ATAHC) is a National Institutes of Health-funded prospective cohort study of the natural history and efficacy of treatment in individuals with recently acquired hepatitis C. Enrollment is open to both human immunodeficiency virus (HIV)-infected and -uninfected individuals. The aim of this article was to evaluate characteristics and virological outcomes among HIV-infected individuals enrolled in ATAHC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom